A test that has been a staple in fertility clinics is now being used to help women predict their fertility, NBC News reported.
The test, now being called the “baby deadline test,” is a simple blood analysis that measures the amount of Anti-Müllerian hormone (AMH) in a woman’s bloodstream. The hormone is released by follicles in the ovaries, indicating the possible number of eggs a woman has left. A higher result means more eggs, while a lower result means fewer eggs.
Women are born with a finite amount of eggs, starting out with roughly one to two million in their ovaries. At puberty, the number drops down to about 300,000 — and by age 30, that number drops by 90 percent.
“There are some young, healthy women who are living their lives in shape and taking very good care of themselves who might not know that their reserve strength of their ovaries is lower than it should be.” said Dr. Joshua Hurwitz with Reproductive Medical Associates of Connecticut. “It’s a question of having the knowledge and awareness of keeping your options open.”